Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202601598052903Phase 0Not yet recruiting
Phase 0, open-label trial of dexmedetomidine, ketamine, lidocaine and fentanyl in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by galal eldeen hasan. Primary endpoint: Pain intensity at rest. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202601598052903.